High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 region

Cytogenetics and Cell Genetics

Volumn 86, Issue 3-4, 1999, Pages 237-239

  Mahlknecht, U ^a,b   Bucala, R ^a   Hoelzer, D ^b   Verdin, E ^c  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE;

ACETYLATION; CHROMOSOME 5Q; CONFERENCE PAPER; DEACETYLATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MAPPING; HUMAN; HUMAN CELL; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

MAMMALIA;

EID: 0032719439     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015347     Document Type: Conference Paper

References (10)

1. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS: Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics 19:425-432 (1994).
2. Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E: Characterization of a human RPD3 ortholog, HDAC3. Proc natl Acad Sci, USA 95:2795-2800 (1998).
3. Kim UJ, Birren BW, Slepak T, Mancino V, Boysen C, Kang HL, Simon MI, Shizuya H: Construction and characterization of a human bacterial artificial chromosome library. Genomics 34:213-218 (1996).
4. Le Beau MM, Espinosa R 3rd, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA: Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc natl Acad Sci, USA 90:5484-5488 (1993).
5. Mahlknecht U, Emiliani S, Najfeld V, Young S, Verdin E: Genomic organization and chromosomal localization of the human histone deacetylase 3 gene. Genomics 56:197-202 (1999).
6. Randhawa GS, Bell DW, Testa JR, Feinberg AP: Identification and mapping of human histone acetylation modifier gene homologues. Genomics 51:262-269 (1998).
7. Schuler GD, Epstein JA, Ohkawa H, Kans JA: Entrez: molecular biology database and retrieval system. Meth Enzymol 266:141-162 (1996).
8. Van den Berghe H, Michaux L: 5q-, twenty-five years later: a synopsis. Cancer Genet Cytogenet 94:1-7 (1997).
9. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971 (1993).
10. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R 3rd, Larson RA, Le Beau MM: Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proc natl Acad Sci, USA 94:6948-6953 (1997).